1. C.J. Malemud, Changes in proteoglycans in osteoarthritis: Biochemistry, ultrastructure and biosynthetic processing. J. Rheumatol. (Suppl. 27), 18 (1991) 60–62.
2. T.I. Morales, Polypeptide regulators of matrix homeostasis in articular cartilage. In K.E. Kuettner, R. Schleyerbach, J.G. Peyron and V.C. Hascall (eds.), Articular Cartilage and Osteoarthritis, Raven Press, New York, 1992, pp. 265–278.
3. D.D. Dean, J. Martel-Pelletier, J.P. Pelletier, D.S. Howell and J.F.Jr. Woessner, Evidence for metalloproteinase and metalloproteinase inhbitor (TIMP) imbalance in human osteoarthritic cartilage. J. Clin. Invest, 84 (1993) 678–685.
4. J.P. Pelletier, J. A. Dibatista, P. Roughley, R. McCullum and J. Martel-Pelletier, Cytokines and inflamation in cartilage degradation. Rheum. Dis. Clin. N. Am., 19 (1993) 545–568.
5. A.J. Pons, L.A. van de Loo, B. Joosten, L.E.M. van Lent, O.J. Arntz and W.B. van den Berg, Role of interleukin-1, tumor necrosis factor-α, and interleukin-6 in cartilage proteoglycan metabolism and destruction effects of in situ blocking in murine antigen- and zymosan-induced arthritis. Arth. Rheum., 38 (1995) 164–172.